IMR Press / RCM / Special Issues / adult_congenital_heart_disease

Adult Congenital Heart Disease: Diagnosis, Prognosis and Management

Section: Heart Diseases
Submission deadline: 30 November 2022
Special Issue Editors
  • George Giannakoulas, MD, PhD
    School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Interests: adult congenital heart disease; pulmonary hypertension; heart failure
  • Alexandra Arvanitaki, MD, PhD
    1st Cardiology Department AHEPA University Hospital, Thessaloniki, Greece
    Interests: adult congenital heart disease; pulmonar hypertension; artificial intelligence; coronary artery disease; heart failure; pregnancy; dyslipidemia
Special Issue Information

Dear Colleagues,

Advances in congenital heart disease (CHD) have radically changed the prognosis and burden of the disease. More than 90% of patients with CHD are now surviving to adulthood and adults account for over two-thirds of the contemporary CHD population in Western countries. Although outcomes have improved, surgery does not cure CHD. Decades of longitudinal observational data are currently motivating a paradigm shift toward a lifespan perspective and proactive approach to CHD care. Multimodality imaging and other biomarkers are paramount in diagnosing and reliably evaluating the severity of structural complications that may arise over the lifespan. Furthermore, advances in the field of interventional therapies have enabled management of multiple defects and complications, obviating the need for an open-heart surgery. Despite all the progress made over the years, there are still patients with increased morbidity burden who require close follow-up and a multidisciplinary team approach to deal with multi-system complications. Finally, early evaluation for transplantation is also important for patients with advanced heart failure. In this Special Issue "Adult congenital heart disease: diagnosis, prognosis and management", we aim to publish papers that focus on all current issues of adult patients with congenital heart disease that include but are not limited to:

1. Diagnostic methods in ACHD

2. Multimodality imaging in ACHD

3. Biomarkers in ACHD

4. Prognostic tools in ACHD

5. Therapeutic approach in ACHD

6. Management of multisystem complications in ACHD

7. Interventional procedures and devices in ACHD

8. Management of ACHD comorbidities

Prof. George Giannakoulas and Dr. Alexandra Arvanitaki

Guest Editors

Keywords
adult congenital heart disease
multimodality imaging
biomarkers
prediction models
surgical approach
interventional therapies
multisystem complications
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Back to top